4.61 USD
↗ 0.00 (0.00%)AT CLOSE (AS OF 08:01 PM EDT)
NRX Pharmaceuticals, Inc. Common Stock
NRXPNASDAQ • USD
Market: CLOSED
Open?$4.65
High?$5.06
Low?$4.58
Prev. Close?$4.62
Volume?2.2M
Avg. Volume?1.4M
VWAP?$4.83
Rel. Volume?1.54x
Bid / Ask
Bid?$3.95 × 100
Ask?$5.36 × 100
Spread?$1.41
Midpoint?$4.66
Valuation & Ratios
Market Cap?167.4M
Shares Out?36.2M
Float?28.9M
Float %?90.6%
P/E Ratio?N/A
P/B Ratio?-12.11
EPS?-$0.68
Dividend?0.00%
Ex-Dividend?N/A
NRX Pharmaceuticals, Inc. Common Stock (NRXP) is currently trading at $4.61. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (177.6%), a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 2, 2026.
News
Profile
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Address
1201 ORANGE STREET
WILMINGTON, DE 19801
Phone: 484-254-6134
WILMINGTON, DE 19801
Phone: 484-254-6134
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?62
Short Sent.?46
Piotroski F-Score?0/9Weak
Altman Z-Score?-38.71Distress
Confidence?46%Low
Short InterestHigh
Short % of Float?16.17%High
Short Interest?4.7M
Days to Cover?4.2
Free Float28.9M
Avg Daily Volume1.1M
Settlement Date2026-05-15
Financial Health
Current Ratio?0.29Weak
Quick Ratio?0.29Weak
Cash Ratio?0.27Low
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-12.11CHEAP▾
S&P97
P/S?73.00HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-9.4CHEAP▾
S&P97
EV/Sales?70.07HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?177.6%STRONG▾
Peers50
S&P97
ROA?-206.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$160.7M
Fundamentals ratios updated end of day